VibroSense Dynamics develops, manufactures and sells medical devices that support diagnosis of peripheral sensory neuropathy. The company was founded in 2005 with headquarters in Malmö, Sweden. Our customers are primary care, hospitals, diabetes clinics, occupational healthcare and research scientists.
Extern länk för VibroSense Dynamics AB
The VibroSense Meter II is built on advanced technology to measure and analyse the neurological function in hands or feet by examining and quantifying the ability to perceive fine-tuned vibration at multiple frequencies on the skin. The evolution of the VibroSense Meter II is based on more than three decades of experimental and clinical research addressing peripheral sensory neuropathy of the hand and foot. The VibroSense Meter II can find changes in the vibration sensitivity before they have developed into permanent nerve damage. VSM II is intended for primary and specialist care, researchers and occupational health care that work with surveillance, treatment, diagnosis or rehabilitation of peripheral neuropathy in the feet or hands. Support for diagnosis of peripheral sensory neuropathy, which may be caused by diabetes or cancer treatment with chemotherapy Research for quantification of neuropathy in various diseases or due to medical treatment
Per Albin Hanssons väg 41
MEDEON Science Park
Malmö, Skane County 214 32, SE
VibroSense Dynamics VD Tarik Cengiz intervjuad av Kalqyl.
Vi har intervjuat Tarik Cengiz, VD på VibroSense Dynamics AB, i samband med bolaget Q1'24/25-rapport. Vi diskuterar bland annat bolagets affärs- och prismodell, fokuset på OEM och distributörer samt geografisk expansion. Se hela intervjun här: https://lnkd.in/dW979w2X
Vi #anställer. Känner du någon som kanske är intresserad?
Our new CEO takes office today The board of directors which to welcome our new CEO Tarik Cengiz who will lead the company to a next level, extending the business to distributors and OEM customer. Very welcome Tarik! Read more at https://lnkd.in/dfYi_b2q #Diabetes #DiabeticFoot #VibroSenseMeter #MultiFrequencyVibrometry
Receives a new patent in the EU VibroSense Dynamics AB has received a so-called "Intention To Grant" on its patent application in the EU, which strengthens the protection for the product VibroSense Meter® II. The patent describes a principle for measuring skin temperature wirelessly before and during an examination, which ensures measurement quality. Read more at https://lnkd.in/dqdhCn3r #vibrosensemeter
Strengthens the organization with a new CEO VibroSense Dynamics strengthens the organization by recruiting Tarik Cengiz as new CEO. Tarik will start his position as CEO on September 16, 2024 after he leaves his previous position as Global Sales Director at Arcoma AB. Read more at https://lnkd.in/dQgxBshu #peripheralneropathy #diabetes #diabeticneuropathy #vibrosensemeter
Empowering the World with Screening of Vibration Exposed workers As an honoured exhibitor we have got very high interest from Occupational Hygienists from all over the world at the international BOHS/IOHA congress in Dublin Ireland. Our HAVS Screening examination has been demonstrated to people from New Zealand, Australia, Singapore, Saudi Arabia, South Africa, EU, UK, USA and Brazil. Read more at https://lnkd.in/ggrZSC4T
All things you wanted to know but did not dare to ask about Peripheral Neuropathy! The link below provide a good explanation about this condition However there is one important flaw, i.e. they never heard about the VibroSense Meter II which is novel and very powerful device to facilitate diagnosis of Peripheral Neuropathy. Read more at https://lnkd.in/ddhpBxfH Learn about Peripheral Neuropathy https://lnkd.in/dhWNda3j #Peripheral_Neuropathy #Diabetes #Chemotherapy
New Patent approval in China VibroSense continuously enhance the company's IP protection. Read more at https://lnkd.in/dCk8ehSk
Join us on our journey to become the "the new Gold Standard for reliable detection of nerve damage". VibroSense currently offers a share issue in order to reach the next level in our international expansion. Read more at https://lnkd.in/dzibWDbD
A huge market is waiting, once we get a regulatory approval which is getting close. VibroSense just received a "Notice of Acceptance" from the Chinese regulatory authority NMPA, i.e. China FDA. We expect to have a Chines certificate at the end of this year where after we can start out delivery which means a sale of at least 3.8 MEUR during three years. Read more in our press release https://lnkd.in/dfhU4R2D
Senaste finansieringsrunda
Anslag55 246,00 US$